Alpha 1-antitrypsin and survival in pancreatic cancer.

Abstract excerpt

The association between serum levels of alpha 1-antitrypsin (a1AT) at the time of diagnosis and survival was studied in a group of 44 patients with confirmed pancreas cancer. All 44 patients were followed until time of death, which occurred in all cases from pancreas cancer, with a median time of 3 months and a range of 0.5 to 16 months. Cox's proportional hazards model was utilized in the analysis controlling...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to alpha 1-Antitrypsin
• Share to Pancreatic Neoplasms
• Share to Phenotype